Tag: biomedical

  • Synthetic Spider Silk Developed with Customized Properties

    28 May 2015. Materials scientists and engineers developed and produced samples of synthetic spider silk, with a process that can adjust the silk’s properties to meet special demands of users. The team from Massachusetts Institute of Technology and Harvard University, led by MIT engineering professor Markus Buehler, published its findings earlier this month in the…

  • Genome Interpretation Database, Quality Effort Underway

    28 May 2015. A program to improve diagnostics and research based on genomic variations is underway that collects genetic data and implements standards for their interpretation. A description of the Clinical Genome Resource or ClinGen program appears in yesterday’s issue of the New England Journal of Medicine. ClinGen is a collaborative effort of  public, academic,…

  • Alliance Building Platform Against Drug-Resistant Infections

    27 May 2015. A coalition of health care providers, academic labs, and a pharmaceutical company formed an organization to develop a common research platform for countering multi-drug aesistant infections. The group known as Share ID — short for sharing hospital data to advance research and enhance patient care in infectious diseases — is underwritten by specialty…

  • Software Companies Integrate Cancer Analytics, Patient Mgmt

    26 May 2015. Two companies with software addressing different perspectives of cancer care agreed to offer an integrated version of their products. Flatiron Health in New York, a developer of cancer analytics, and Varian Medical Systems in Palo Alto, California, a provider of decision support software for cancer care, announced the deal today, but released…

  • Study IDs Advanced Prostate Cancer Genome Mutations

    22 May 2015. An analysis of biopsy samples from men with prostate cancer that spread to other parts of their bodies identifies genomic anomalies found in nearly 90 percent in men with the condition, for which treatments may be available. Findings from the team at eight institutions in the U.S. and U.K. appear today in…

  • Mobile App Data Provided for Chronic Pain Study

    21 May 2015. Data collected by a mobile app designed to help individuals manage their pain are being provided to a research lab at York University to reveal patterns in painful experiences by the app’s users. York’s Human Pain Mechanisms Lab in Toronto, Ontario, Canada will analyze data provided by the app Manage My Pain,…

  • Orphan Status Granted Eye Cancer Treatment

    21 May 2015. Food and Drug Administration designated an experimental treatment for uveal melanoma, a rare and aggressive form of cancer in the eye, as an orphan drug that qualifies for incentives to expedite its development. Aura Biosciences also revealed results of preclinical tests showing the ability of its lead biologic therapy code-named AU-011 to…

  • Phillips, MIT Form Health Technology Collaboration

    20 May 2015. Electronics manufacturer Royal Phillips and Massachusetts Institute of Technology are collaborating on research into health care technology and digital urban lighting systems. The 5-year, $25 million agreement also includes moving the company’s North American research and development center to Cambridge, Massachusetts near the MIT campus. Phillips, headquartered in the Netherlands, designs and…

  • FDA Approves Four-Times-Per-Year Schizophrenia Drug

    19 May 2015. Food and Drug Administration approved for sale in the U.S. a drug for controlling schizophrenia symptoms that individuals need to take only four times per year. Janssen Pharmaceuticals, a division of Johnson & Johnson, markets the three-month version of the drug paliperidone palmitate under the brand name Invega Trinza. Schizophrenia is a…

  • Lab-On-Chip Device Captures Circulating Tumor Cells

    19 May 2015. Engineers and medical researchers designed a microchip that detects clusters of circulating tumor cells that break away from tumors and can spread cancer throughout the body. The team from a joint Harvard-MIT health sciences technology program and Massachusetts General Hospital in Boston published its findings yesterday in the journal Nature Methods (paid…